Josephson, Cassandra D <br/><br/>
The new albumin-free recombinant factor VIII concentrates for treatment of hemophilia: do they represent an actual incremental improvement?  [electronic resource] 

 -  Clinical advances in hematology & oncology : H&O  Jul 2004 
 - 441-6 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1543-0790 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Albumins<br/>Animals<br/>Blood Coagulation Tests<br/>Blood-Borne Pathogens<br/>CHO Cells<br/>Cell Line<br/>Cell Line, Transformed<br/>Child<br/>Child, Preschool<br/>Clinical Trials as Topic<br/>Cricetinae<br/>Cricetulus<br/>Drug Contamination<br/>Factor VIII--economics<br/>Hemophilia A--drug therapy<br/>Humans<br/>Infant<br/>Infection Control--methods<br/>Male<br/>Mesocricetus<br/>Middle Aged<br/>Multicenter Studies as Topic<br/>Recombinant Proteins--chemistry<br/>Transfection<br/>Treatment Outcome